Estimating the False-Positive Rate of Highly Automated SARS-CoV-2 Nucleic Acid Amplification Testing.
作者信息
Chandler Christopher M, Bourassa Lori, Mathias Patrick C, Greninger Alexander L
机构信息
Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.
Department of Biomedical Informatics and Medical Education, University of Washington School of Medicine, Seattle, Washington, USA.
出版信息
J Clin Microbiol. 2021 Jul 19;59(8):e0108021. doi: 10.1128/JCM.01080-21.
Abstract
摘要
相似文献
1
Estimating the False-Positive Rate of Highly Automated SARS-CoV-2 Nucleic Acid Amplification Testing.
J Clin Microbiol. 2021 Jul 19;59(8):e0108021. doi: 10.1128/JCM.01080-21.
2
Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting.
Clin Microbiol Infect. 2021 Mar;27(3):469.e9-469.e15. doi: 10.1016/j.cmi.2020.10.003. Epub 2020 Oct 14.
3
Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00772-20.
4
Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01136-20.
5
A study of quality assessment in SARS-CoV-2 pathogen nucleic acid amplification tests performance; from the results of external quality assessment survey of clinical laboratories in the Tokyo Metropolitan Government external quality assessment program in 2020.
J Infect Chemother. 2022 Feb;28(2):242-247. doi: 10.1016/j.jiac.2021.10.027. Epub 2021 Nov 10.
6
Development and comparison of novel multiple cross displacement amplification (MCDA) assays with other nucleic acid amplification methods for SARS-CoV-2 detection.
Sci Rep. 2021 Jan 21;11(1):1873. doi: 10.1038/s41598-021-81518-8.
7
High-Throughput Transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-2.
J Clin Virol. 2020 Aug;129:104501. doi: 10.1016/j.jcv.2020.104501. Epub 2020 Jun 10.
8
Development and Clinical Application of a Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for SARS-CoV-2 Infection.
mSphere. 2020 Aug 26;5(4):e00808-20. doi: 10.1128/mSphere.00808-20.
9
Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2.
J Virol Methods. 2020 Nov;285:113970. doi: 10.1016/j.jviromet.2020.113970. Epub 2020 Sep 10.
10
SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment.
Lancet. 2022 Apr 30;399(10336):1690-1691. doi: 10.1016/S0140-6736(22)00577-3. Epub 2022 Apr 7.
引用本文的文献
1
Use of a Multiplex Immunoassay Platform to Investigate Multifaceted Antibody Responses in SARS-CoV-2 Vaccinees with and Without Prior Infection.
COVID. 2025 Apr;5(4). doi: 10.3390/covid5040044. Epub 2025 Mar 22.
2
Testing for SARS-CoV-2: lessons learned and current use cases.
Clin Microbiol Rev. 2024 Jun 13;37(2):e0007223. doi: 10.1128/cmr.00072-23. Epub 2024 Mar 15.
3
Pre-Operative SARS-CoV-2 Testing in Asymptomatic Heart Transplantation Recipients.
Biomedicines. 2023 Jul 26;11(8):2103. doi: 10.3390/biomedicines11082103.
4
Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital.
JAMA Netw Open. 2022 Oct 3;5(10):e2236288. doi: 10.1001/jamanetworkopen.2022.36288.
5
Rapid Antigen Assays for SARS-CoV-2: Promise and Peril.
Clin Lab Med. 2022 Jun;42(2):203-222. doi: 10.1016/j.cll.2022.03.001. Epub 2022 Mar 4.
6
Biosensor detection of airborne respiratory viruses such as SARS-CoV-2.
SLAS Technol. 2022 Feb;27(1):4-17. doi: 10.1016/j.slast.2021.12.004. Epub 2022 Jan 2.
7
Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario.
Diagn Microbiol Infect Dis. 2022 Mar;102(3):115609. doi: 10.1016/j.diagmicrobio.2021.115609. Epub 2021 Nov 27.
8
SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center.
Wien Klin Wochenschr. 2021 Sep;133(17-18):909-914. doi: 10.1007/s00508-021-01927-7. Epub 2021 Aug 19.
9
Test it earlier, result it faster, makes us stronger: how rapid viral diagnostics enable therapeutic success.
Curr Opin Virol. 2021 Aug;49:111-116. doi: 10.1016/j.coviro.2021.05.007. Epub 2021 Jun 8.
本文引用的文献
1
Two cases of novel coronavirus infection (COVID-19) with transient viral elevation using semi-quantitative real-time reverse transcription PCR and symptom relapse after completion of 10 days of favipiravir treatment.
J Infect Chemother. 2021 Jul;27(7):1072-1075. doi: 10.1016/j.jiac.2020.12.018. Epub 2020 Dec 23.
2
Experience With False-Positive Test Results on the TaqPath Real-Time Reverse Transcription-Polymerase Chain Reaction Coronavirus Disease 2019 (COVID-19) Testing Platform.
Arch Pathol Lab Med. 2021 Mar 1;145(3):259-261. doi: 10.5858/arpa.2020-0612-LE.
3
Comparison of Commercially Available and Laboratory-Developed Assays for Detection of SARS-CoV-2 in Clinical Laboratories.
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00821-20.
4
Validation of laboratory-developed molecular assays for infectious diseases.
Clin Microbiol Rev. 2010 Jul;23(3):550-76. doi: 10.1128/CMR.00074-09.
Zotero 插件